Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Re-evaluation of the metabolism of carbocisteine in a British white population.

Pharmacogenetics - 1 Oct 1993

Gregory W L, James O F, Turner I, Meese C O, Idle J R

Abstract excerpt

It has been claimed that the amino acid derivative carbocisteine is predominantly metabolized by sulfoxidation and that this pathway exhibits a genetic polymorphism. Moreover, those subjects with a 'poor metabolizer' phenotype have been thought to have a genetic predisposition to developing certain diseases. We have confirmed the observations of others that this marker drug does not undergo significant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Biotransformation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Phenotype

Share to Polymorphism, Genetic

Share to United Kingdom

Share to White People

Source

Identifiers

PMID: 8287066
DOI: 10.1097/00008571-199310000-00007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Re-evaluation of the metabolism of carbocisteine in a British white population.PMID 8287066Read ↗

Identification of the "major" polymorphic carbocysteine metabolite as S-(carboxymethylthio)-L-cysteine.Semantic proximity Read ↗

Limitation to the use of the urinary S-/R-mephenytoin ratio in pharmacogenetic studies.Semantic proximity Read ↗

Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populations.Semantic proximity Read ↗

Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways.Semantic proximity Read ↗

An S-mephenytoin cysteine conjugate identified in urine of extensive but not of poor metabolizers of S-mephenytoin.Semantic proximity Read ↗

Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine.Semantic proximity Read ↗

A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.Semantic proximity Read ↗

Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.Semantic proximity Read ↗

Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.Semantic proximity Read ↗

Mephenytoin phenotyping: lack of haematologic effect and timing of urine collections.Semantic proximity Read ↗

A methodological investigation on the estimation of the S-mephenytoin hydroxylation phenotype using the urinary S/R ratio.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.